ACAIM has been closely following an emerging public health situation regarding an outbreak of pneumonia caused by a novel strain of coronavirus, 2019 Novel Coronavirus (2019-nCoV), in Wuhan, China.
This outbreak emphasizes the importance of collaboration amongst providers, public health officials, and international health entities in addressing illness as a joint medical community. As our borders become ever less well-defined, we must work together to adequately address global health challenges. ACAIM is one platform for a multi-specialty approach to international medicine that can create effective solutions to improve the health of our populations around the world.
While coronaviruses commonly infect people often responsible for ‘the common cold’ this "novel coronavirus" is a strain that has not previously been found in humans. It can lead to fever, cough, and shortness of breath. Most people with these infections have reported exposure to a large seafood and live animal market in Wuhan, but there is also some evidence of human-to-human transmission. At this time, the CDC recommends that travelers avoid all non-essential travel to China. This situation is continuously evolving, please refer to the CDC, WHO, and your local Department of Health for the latest recommendations.
All original research abstracts submitted here for consideration for oral presentation and publication in IJAM.
Student submissions that are not original research (i.e. reflections on experiences, investigations, teaching pearls, collaboration, policy development, protocols, etc.) for consideration for oral presentation and publication in IJAM.